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a b s t r a c t
The human estrogen receptor alpha (ERα) mediates the proliferative action of hormones in breast cancer
cells by regulating the expression of target genes to control cellular functions. Current methodologies do
not permit a real-time assessment of these processes in living cells. We overcome this limitation using
electrical cell-substrate impedance sensing for measuring ERα-regulated signaling processes indicative of
the onset of cell proliferation to target them for compound screenings. We report that hormone like
odorants regulate, similarly as natural estrogen, ERα-mediated gene expression involved in mitogenic
and developmental processes in MCF7 breast cancer cells. An odorant concentration-dependent switch
in cell responses was detectable already 10–15 h post-stimulation, providing rapid quantiﬁcation of
hormonal activity before cell division occurred. Though ERα exhibits complex regulatory roles our non-
invasive approach captures its activity for accelerated screenings of compounds promoting breast cancer
cell proliferation expanding the analysis of ERα signaling networks.
& 2013 Elsevier B.V. All rights reserved.
1. Introduction
Estrogens are steroid hormones that play a fundamental role in
the physiology of various human tissues, but they are also critical
for the initiation and progression of breast and gynecological
cancers (Conzen, 2008). Their small size and lipophilic properties
allow them to freely traverse the plasma membrane and to directly
inﬂuence target cells (Pick et al., 2007). Estrogen functions are
mediated by estrogen receptors (ERs), members of the nuclear
hormone receptor family. They primarily act as ligand-inducible
transcription factors to modulate the expression of speciﬁc genes,
which regulate multiple body functions (Kininis and Kraus, 2008).
There are two main human ER subtypes, ERα and ERβ, which
exhibit distinct tissue-speciﬁc expression patterns and biological roles
(Thomas and Gustafsson, 2011). Generally ERs can form homo- and
heterodimers before binding to speciﬁc DNA sequences called
estrogen response elements (EREs), inﬂuenced by diverse sets of
ER-interacting proteins that have been described as co-activators or
co-repressors to enhance or suppress transcription activity of target
genes (Metivier et al., 2003). ERs can also indirectly bind to alternative
sites at gene promoters and affect transcription by associating with
stimulating protein-1 (SP1), activator protein-1 (AP1), or other tran-
scription factors (Marino et al., 2006). Finally, gene regulation may
even occur through rapid signaling of membrane-associated ERs.
These pathways involve kinase cascades and second messenger
signaling, which indirectly impact transcription and contribute to the
overall diversity and complexity of cellular processes inﬂuenced by
estrogens (Marino et al., 2006).
ERα is the most abundant ER and an important determinant of
breast cancer biology and treatment as well as a prognostic marker
(Giacinti et al., 2006). It exhibits high speciﬁcity and afﬁnity for its
endogenous ligand 17β-estradiol (E2) but also binds a wide range
of compounds with strikingly diverse structures (Brzozowski et al.,
1997). These include natural products and synthetic chemicals that
may not share any obvious structural similarity to E2, precluding
prediction of their estrogenic activities on gene regulation and
potential adverse health effects on the basis of chemical structure
(Agatonovic-Kustrin et al., 2008).
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An ERα positive human breast cancer cell line (MCF7) currently
serves as the most prominent model system for studying breast
cancer progression and for detecting chemicals with estrogenic
activities (Soto et al., 1995). The number of genes regulated by E2 in
MCF7 cells, ranges from 100 to 1500. These largely appear to be
involved in signaling pathways controlling cell proliferation, invasion
and metastasis (Kininis and Kraus, 2008; Abba et al., 2005). The
ﬁnding that E2 also exhibits similar gene regulation in native human
tumors further validates MCF7 cells as an estrogen signaling model
system relevant to breast cancers (Creighton et al., 2006). The
mitogenic response of MCF7 cells to estrogenic compounds is
considered to be the most sensitive, speciﬁc, and biologically relevant
hallmark of estrogenic activity (Fang et al., 2000). Inﬂuences of
chemicals on MCF7 cell proliferation are usually assayed over a time
period of 4–6 days, sometimes even up to 14 days (Soto et al., 1995;
Charles and Darbre, 2009). This time consuming approach does not
allow for rapid screening of a large number of compounds.
Here we investigated cellular processes preceding the onset of
proliferation with the aim of discovering novel and more rapid
indicators of estrogenic activity. We focused on estrogenic sandal-
wood odorants, which are widely-used in perfumes and fra-
granced body care products. Elsewhere, we demonstrated their
proliferative effects in MCF7 cells mediated by ERα (Pick et al.,
2009). Here, we investigated the effects of sandalwood odorants
on the regulation of gene transcription and activation of cellular
signaling pathways. Such experiments are of importance for better
deﬁning the role of synthetic odorants as activators of ERα as well as
their estrogenic potency in regulating cellular functions. Whereas the
impact of E2 on transcription regulation has been worked out in
considerable detail (Hah et al., 2011), very little is known about the
timing and extent to which estrogen-like chemicals, especially
synthetic odorants interfere with these processes.
To investigate the correlation between ERα-mediated genomic
effects and their phenotypic cellular responses induced by sandal-
wood odorants, we used electrical cell substrate impedance
sensing (ECIS) on cultured MCF7 cells. ECIS is based on the
principle that cells attaching to the electrode act as insulators
increasing the electrical impedance of the electrode (Giaever
and Keese, 1991). The measured impedance depends on (i) the
number of cells covering the electrode, (ii) the strength of cell
attachment, and (iii) the cells' morphology. Stimulation of endo-
genous ERα by compound application activates various cell functions
leading to morphological changes of the cells, which in turn induce
changes in the local ionic environment at the interface between the
electrode and the cells, and thereby modulate the electrode's
impedance. Here, we demonstrate that ECIS is suited for rapid
detection of estrogenic actions and thus enables accelerated com-
pound screening.
2. Materials and methods
2.1. Chemicals and reagents
The following odorants were from Givaudan and Sigma: 3,3-
Dimethyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol, (Poly-
santol, PS); 1-Methyl-2-[(1,2,2-trimethylbicyclo[3.1.0]-hex-3-ylmethyl)
cyclopropyl]methanol, (Javanol, JV); Methyl 2,4-dihydroxy-3,6-dime
thylbenzoate, (Mousse Cristal, MC): these compounds were freshly
dissolved in DMSO before experiments. ICI 182,780 was from Tocris
Biosciences, and 17β-estradiol (E2) was from Sigma.
2.2. Cell culture
MCF7 human breast cancer cells (gift from Ana Soto, Tufts
University, Boston) are dependent on estrogen for proliferation (Soto
et al., 1995) and were grown as stock cultures in Dulbecco's modiﬁed
Eagle's medium (DMEM, Invitrogen) supplemented with 5% fetal
bovine calf serum (Invitrogen) at 37 1C in 5% CO2 atmosphere and
saturating humidity. For hormone depletion, cells were maintained
in phenol-red free DMEM supplemented with 10% of charcoal
dextran-treated calf serum (HyClone) for at least 2 days before an
experiment.
2.3. Real-time reverse transcription polymerase chain reaction
(RT-PCR)
MCF7 cells were seeded into 6-well plastic tissue culture dishes at
a concentration of 5!103 cells/well in 5% charcoal-treated fetal
bovine serum in DMEM. After 24 h at 37 1C with 5% CO2 the seeding
medium was removed and replaced by the experimental medium
(phenol red-free DMEM, 5% charcoal/dextran-treated, heat-
inactivated human serum, from Sigma) supplemented with the
appropriate concentrations of a particular odorant or a mixture of
an odorant and the ER-speciﬁc antagonist ICI 182,780 (10 μM) (Tocris
Bioscience). The assay was terminated by removing the cell media
from the wells and freezing the culture dishes at "80 1C. For real-
time RT-PCR total RNA was extracted with chloroform and processed
with the RNeasy Kit (Qiagen). Total RNA was reverse transcribed
using RT (Life Technology) and random hexamers (Roche). Semi-
quantitative real-time PCR analysis was performed with SYBR Green
PCR Core Reagents system (Qiagen) on a realplex2 Mastercycler PCR
Detection System (Eppendorf) using primers and conditions provided
elsewhere (Ciarloni et al., 2007; Ayyanan et al., 2011).
2.4. Cellular impedance assay
The electrical impedance of MCF7 cells cultured on an array of
microelectrodes integrated at the bottom of individual compartments
of a 96-well E-plate (xCelligence sytem, Roche) was measured. Cells
attaching to the electrode act as insulators, and increase the electrical
impedance of the electrode. Stimulation of endogenous ERα by
compound application activates various cell functions leading to
morphological changes of the cells, which in turn ﬁnally induce
changes in the local ionic environment at the electrode/cell interface,
and modulate the electrode impedance, displayed by the cell
impedance index (CI). The CI is a dimensionless parameter calcu-
lated as the difference between the impedance of cell-covered and
cell-free electrodes measured at 10 kHz and divided by a frequency
factor (R¼15Ω). For a better comparison of impedance responses
between different samples, the measured cell impedance indices
within a time series of one sample were normalized by the particular
value measured at the time of addition of odorants. This procedure
corrected for minimal differences in cell growth between the samples
in the different wells. Furthermore, from each normalized CI value
the particular CI value before (or with the lowest) stimulation
was subtracted to highlight the estrogenic effects. After this
double correction, data were referred to as “baseline normalized
cell indices”. Typically 30,000 cells were seeded per well in
DMEM medium with 10% of charcoal/dextran-treated, heat-
inactivated human serum, 15 mM HEPES and 100 μg/ml penicillin-
streptomycin (Invitrogen) and grown for 16–20 h before ligand
addition. Electrical impedance values were recorded continuously
every 30 min. Finally, the estrogenic effect was obtained by ﬁtting the
baseline normalized cell indices with a Langmuir equation using both
the maximal impedance amplitudes reached after 40–50 h and the
slope of the early linear ascending phase observed 10–24 h after
stimulation. Curve ﬁtting was performed using Igor software (Wave-
metrics). All data represent means of at least three independent
experiments.
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3. Results
3.1. Real-time RT-PCR analysis of odorant-mediated gene
expression proﬁles
We assessed the ability of the fragrance odorants Javanol (JV),
Polysantol (PS), and Mousse Cristal (MC), (chemical structures
depicted in Fig. 1A) to regulate expression of several established
estrogen-responsive genes in MCF7 cells. Transcription of genes
for progesterone receptor (PR), amphiregulin (AR), ERα, and
wingless-type MMTV integration site family, member 4 (Wnt4)
was quantiﬁed over time. All of these proteins play critical roles in
cell proliferation and mammary gland development (Ciarloni et al.,
2007; Brisken et al., 2000; Brisken and O’Malley 2010).
After 7 days of estrogen deprivation, MCF7 cells were exposed
to a particular odorant (always at 100 μM) for distinct time periods
between 30 min and 8 h. Total RNA extracts of these cells were
analyzed using real-time reverse transcription PCR (RT-PCR) and
compared to RNA samples from cells which were stimulated with
1 nM E2 for 4 h and 8 h. Our results indicate that odorant-
mediated effects on gene regulation compare well to those elicited
by the natural hormone (Fig. 1).
Transcripts of PR, WNT4 and AR were up-regulated whereas
ERα was down-regulated by all of the odorants. JV and PS
increased transcription of PR and AR to the same high extent as
E2, whereas WNT4 mRNA was slightly less up-regulated ($60% of
the transcript level obtained for E2). Within 1–2 h after odorant
stimulation changes in transcript levels were observed, which
continued to increase over time.
MC evoked signiﬁcantly lower gene regulatory effects indicat-
ing weaker estrogenic activity. The effects of odorants and E2 on
transcription were inhibited by the antiestrogenic compound ICI
182,780 suggesting the involvement of an ERα mediated mechan-
ism. We next investigated the time required for genomic effects to
manifest into measurable phenotypic changes after odorant appli-
cation by employing electrical impedance sensing as a non-
invasive technique to capture the global cellular responses in
real-time.
3.2. Impedance responses reveal different signatures of estrogenic
odorants
The interactions of cells with underlying electrodes were
followed by electrical impedance spectroscopy at 10 kHz (details
in: supplementary Note 1, Fig. S1, and Table S1). In the initial phase
($20 h) after seeding MCF7 cells adhered and spread on sensing
electrodes. This resulted in a slight increase of impedance values
over time with similar kinetics for all cell samples (Fig. 2A). As the
electrical impedance detects with high sensitivity small cell
morphological changes (Giaever and Keese, 1991), which are
directly related to alterations in cellular activities, it allows cellular
signaling to be quantiﬁed (Yu et al., 2006).
After electrode adherent cells were exposed to 0.1 nM of the
natural hormone E2 or 50 mM of the odorants PS and JV, an
exponential increase of the impedance was observed. The impe-
dance responses to E2 and the odorants PS and JS closely
resembled each other with respect to curve shape, kinetics, and
amplitudes (Fig. 2A). A slight increase in impedance upon addition
of apparently hormone-free cell medium indicated a minor back-
ground cell proliferation, which might be induced by traces of
hormones remaining in the serum supplemented to the medium.
This effect was largely suppressed by the addition of the antago-
nist ICI 182,780 (Fig. 2A). When essential nutrients became
depleted, the impedance leveled off and then decreased due to
lower cell adhesion. Compared to the other odorants, MC (100 μM)
showed a different impedance signature with a delayed response.
Fig. 1. RT-PCR reveals similarities in patterns of gene expression induced by
odorants and E2 in MCF7 cells. (A) Hormone-depleted MCF7 cells expressing
endogenous ERα were challenged with the odorants Polysantol (PS, 100 μM),
Javanol (JV, 100 μM), Mousse Cristal (MC, 100 μM) and with E2 (1 nM) for the
indicated times in B. (B) Total RNA was extracted from all samples and real-time
RT-PCR revealed transcription up-regulation of PR, WNT4 and AR and the down-
regulation of ERα by the estrogenic odorants (left) and E2 (right). The inhibition of
ERα-mediated transcription by co-application of the anti-estrogenic compound ICI
182,780 (10 μM) for 8 h is shown for each odorant and E2. Measurements are
subtracted with the background transcription value obtained before ligand appli-
cation and are given as induction factor relative to the endogenous control
transcript TBP (TATA-box binding protein). Data represent means and standard
deviations of three independent experiments.
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After a small immediate increase, the impedance value remained
at the same level for several hours until it rose again and reached
an amplitude, which was signiﬁcantly lower than that observed
for the other compounds (Fig. 2A) suggesting that MC has lower
estrogenic activity than PS and JV.
All impedance responses of MCF7 cells were found to be ERα
selective. Co-application of the ERα selective antagonist ICI
182,780, which strongly inhibited cell proliferation (Kariagina
et al., 2010) also suppressed the impedance response for E2
(Fig. 2A) and all tested odorants (Fig. 3).
Next we analyzed which features of the impedance response
could be quantiﬁed to evaluate dose-dependent effects of com-
pounds on cellular responses. The curves were baseline-corrected
and normalized as described in Section 2. Fig. 2B, shows baseline
normalized cell index recordings of PS-mediated effects on MCF7
breast cancer cells as a function of odorant concentration. The
maximum amplitudes of the cell indices, which were reached
approximately 40 h after stimulation can be used to measure the
concentration dependence of estrogenic effects (Fig. 2C).
A closer analysis revealed odorant dose-dependent differences
in the slope of the early ascending phase of the impedance
response initiated already 10–15 h after exposure to PS (Fig. 2B,
inset). Moreover, the initial slope of the cell indices allowed the
estrogenic effect to be quantiﬁed with a similar accuracy as when
using the maximal amplitudes (Fig. 2C). In Fig. 3, the effect of E2 and
all odorants could be detected already 10 h after stimulation, while
the effect of the antagonist appeared immediate at the chosen time
resolution (o30 min). This shows that estrogenic activities can be
quantiﬁed considerably faster by impedance measurements than by
classical cell proliferation assays.
The EC50 values of the different compounds obtained from
ECIS compare well with data obtained from different biochemical
tests (Pick et al., 2009). According to the impedance responses the
signatures of JV and PS are characteristic of full agonists of ERα.
They elicit the same maximum response are the same as for E2,
but their EC50 values are shifted to the micro-molar range,
whereas MC has a distinctly smaller maximal effect.
4. Discussion
Some sandalwood odorants can have a profound effect on cell
division in human breast cancer MCF7 cells (Pick et al., 2009). As
proliferation of MCF7 cells is controlled by ERα-mediated gene
Fig. 2. Sensing the effect of different compounds onMCF7 cell proliferation by electrical
impedance measurements. (A) The initial $20 h of recordings reﬂect the phase of cell
attachment and spreading. Then electrical impedance measurements were performed
for another 70 h after adding particular odorants and E2 at time “0” at the following
concentrations: E2 (0.1 nM), PS (50 μM), JV (50 μM), MC (100 μM). Control measure-
ments show the effect of adding cell medium or blocking the response of E2 by
co-application of ICI 182,780 (1 μM). Data represent means of at least three independent
experiments (7SEM). (B) Representative dose-dependent impedance measurements of
MCF7 cell proliferation stimulated by Polysantol at the indicated concentrations. Cell
Indices were normalized and baseline-corrected as described in the Materials and
Methods section. Inset enlargement of the ﬁrst ascending phase (10–24 h) post-
stimulation. (C) The slope of the initial ascending phase of the cell index versus time
and impedance maxima generate almost identical concentration response curves. Full
symbols represent concentration response curves obtained by plotting the maximal CI
values versus the corresponding compound concentration. Open symbols represent
concentration response curves describing the slope of the early increase of cell indices
versus time (Fig. 2B). Data represent means and standard deviations of at least three
independent experiments.
Fig. 3. Effect of the antagonist on the impedance response of MCF7 cells after
stimulation by odorant fragrances. Impedance response of MCF7 cells after
stimulation by odorants (100 mM) and E2 (1 nM) in the presence (dashed lines)
and in the absence (continuous lines) of the antagonist ICI 182,780 (1 mM). The
antagonist fully blocks the impedance response of the cell proliferation for the
4 tested compounds at the concentrations used. In addition the antagonist induces
an immediate and transient decrease of impedance before any effect of odorants
can be detected.
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regulation (Soto et al., 1995; Hu et al., 2011) we analyzed the time-
course of odorant-induced transcription of ERα regulated genes in
mitogenic and developmental processes. We characterized the
time point of onset of transcriptional responses to subsequently
relate these processes to early measurable phenotypic outcomes
for the development of rapid assay readouts. RT-PCR revealed
quite immediate odorant inﬂuences on gene transcription, which
were detectable $1 h after application. Only recently it has been
shown that E2 signiﬁcantly affects a large fraction of the MCF7
transcriptome ($26%) within 1 h of treatment (Hah et al., 2011).
Here, we provided the ﬁrst evidence that the rapid transcriptional
activation of ERα by speciﬁc odorant molecules is similar to the
effect evoked by E2 in MCF7 cells.
The gene expression pattern induced by the odorants was very
similar to that observed with E2. Highest up-regulation was
measured for the progesterone receptor (PR), a ligand-activated
nuclear transcription factor that promotes expression of genes
involved in various signaling pathways of female reproduction
(Graham and Clarke, 2002). Both PR and ER control normal breast
development and are implicated in the etiology of breast cancer
(Brisken and O’Malley 2010). The functional impact of PR in
promoting MCF7 cell proliferation has been proven elsewhere
(Chen et al., 2012).
Sandalwood odorants also up-regulated human amphiregulin
(AR), a ligand for the epidermal growth factor receptor (EGFR)
essential for mammary gland development (Busser et al., 2011). It
induces proliferation of mammary glands upon estrogen and pro-
gesterone stimulation and activates the ERK, Akt and JNK signaling
pathways to regulate cell proliferation (Kariagina et al., 2010).
Finally, we also observed odorant-mediated up-regulation of
the wingless-type MMTV integration site family, member 4
(Wnt4) transcript. Wnt signaling is involved in multiple develop-
mental processes as well as in breast cancer cell proliferation (Hu
et al., 2011). Furthermore, Wnt4 expression is mediated in an ERα-
dependent manner (Brisken et al., 2000). The down-regulation of
ERα transcription by E2 is established (Frasor et al., 2004) and we
have shown here that the odorants regulate this gene in the same
way as the natural ligand.
The time span between the initiation of ERα-mediated gene
expression and the resulting cellular phenotypic changes is poorly
characterized, and might take several hours. We have shown here
that ECIS can be used to shed light on these processes. As a central
ﬁnding we observed that sandalwood odorants induced signiﬁcant
changes in cellular activities of MCF7 cells, which could be
measured by increased impedance starting between 10 and 15 h
after stimulation. This impedance response was odorant dose
dependent and inhibited by the antiestrogen ICI 182,780 indicat-
ing that these effects were mediated by ERα. Transcript levels
induced by odorants were high at about 8 h after induction, as
shown by our RT-PCR measurements. This result implies that a
certain level of gene activation is required to cause subsequent
cellular responses. We have demonstrated here that ECIS is
capable of monitoring early cellular processes in response to
endogenous ERα activation. This ﬁnding is important as it allows
a much faster determination of estrogenic activities of chemicals
compared to conventional MCF7 cell proliferation assays which in
turn will accelerate the selection of compounds for further
analyses focusing on their impact on human health. Our quanti-
tative cellular response measurements provide information not
only on the time frame of activation but also on the character of
the ligand.
Only a few volatile compounds with estrogenic activity have
yet been reported and sparse knowledge exists about their impact
on transcription regulation. A recent study showed up-regulation
of a single marker gene by benzylphenylmethylpropional (Lilial,
commercially used in perfumes) in MCF7 cells at concentrations
similar to those used in our present study (Charles and Darbre
2009; Pick et al., 2009), We provide here initial evidence for
extended regulatory activities of synthetic odorants on a set of
ERα-dependent genes suggesting potentially broad inﬂuences of
these compounds on cellular processes. While we have shown that
sandalwood odorants modify gene transcription rapidly, reaching
amplitudes comparable to those elicited by E2, signiﬁcantly lower
effects were reported for Lilial. Furthermore, transcription mod-
ulation by this odorant was only detected after longer exposure
times ($24 h) (Charles and Darbre 2009). Some polycyclic musk
fragrances exhibited anti-estrogenic effects in cell proliferation
(Schreurs et al., 2005), while a small number of nitro musk
fragrances slightly increased the rate of MCF7 cell divisions. For
all of these substances, the estrogenic potency was low compared
to E2 (Bitsch et al., 2002). Elsewhere, we have shown that
sandalwood odorants substantially increased MCF7 proliferation
to a similar extent as E2 but at elevated concentrations (Pick et al.,
2009). This further underscores their role as ERα-speciﬁc agonists.
Several thousands of yet uncharacterized chemicals might
interfere with ER functions. A remaining challenge is to show
why a range of structurally diverse chemicals can mimic estrogenic
actions. To this end we have demonstrated that our methodology
delivers information-rich impedance response proﬁles on kinetics,
strengths and duration of cellular responses induced by activated
ERα. This allows the potency of estrogenic compounds to be
quantiﬁed and compared to the natural hormone. More systematic
research needs to be done to reveal and to dissect which speciﬁc
impedance proﬁle features may be indicative of partial or full
agonist or antagonist responses on ERα.
It is difﬁcult to speculate whether or not single odorant
compounds may reach sufﬁcient concentrations to produce an
estrogenic response in native breast tissues. Experimental ﬁndings
show at least that lipophilic odorant molecules accumulate and
concentrate in human adipose tissue and in human breast milk
(Rimkus andWolf, 1996). Such an enrichment of diverse estrogenic
compounds might create an estrogenic burden with adverse
effects on human health (Soto et al., 1995). Different estrogenic
compounds may act in a synergistic manner on the modulation of
ERα activity, where each compound alone would have only little
effect (Evans et al., 2012). The possibility that various cellular
activities can be integrated in the impedance measurements
should make ECIS useful for investigating such cumulative effects
on ERα. Furthermore, since ECIS is a label-free method, it is ideally
suited to analyze primary cells: to monitor for instance cancer
development related to ERα as well as to functionally characterize
other complex cellular signaling processes.
5. Conclusions and future perspectives
Our studies have shown that particular synthetic sandalwood
odorants widely used in perfumes and fragranced body care
products, rapidly activate ERα-mediated gene expression resulting
in the promotion of cell proliferation in hormone-sensitive human
MCF7 breast cancer cells, which demonstrates their estrogenic
activity. Compared to the long duration of conventional prolifera-
tion assays lasting over several days, we show that electrical cell-
substrate impedance sensing (ECIS) is a new method, which
substantially accelerates the detection and quantiﬁcation of pro-
liferative responses in MCF7 for the screening of estrogenic
chemicals.
To date a few hundreds of man-made chemicals are known to
possess estrogenic activity. However, thousands of other chemicals
have not been tested but are anticipated to potentially modulate
natural hormonal systems in human or wildlife species (Rotroff
et al., 2013). National and international governments speciﬁcally in
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USA, Japan, EU and other OECD countries are in the process of
establishing testing programs to assess the safety of currently used
chemicals regarding their hormone disrupting potential (Hecker
and Hollert, 2011). Combining our non-invasive ECIS approach
with modern microﬂuidic devices will facilitate such comprehen-
sive screenings of chemicals for determining not only their
estrogenic activities but very general their cytotoxic effects, which
from legal commercial, medical and environmental aspect will
become increasingly important in the future.
Furthermore, as our approach integrates all cellular activities
into single real-time measurements, it also provides a promising
strategy for analyzing the regulation of complex ERα signaling
networks, opening new possibilities for studying the role of this
receptor in physiological and cancer processes.
In a different way, the ECIS technique can be used to address
the heterogeneity of tumor cells, which is of utmost importance
for the analysis of tumor behavior in response to therapy. Recent
reports have revealed the metastatic potential of different cell
lines (Tarantola et al., 2010) and the acquired drug resistance of
MCF7 cells (Eker et al., 2013). Through further electrode miniatur-
ization, ECIS could be extended to the single-cell level offering
new possibilities in cancer diagnosis.
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